Skip to main content
Caplight Logo









Incospharm Corporation

Incospharm Corporation

Private
DaejeonHealthcare & Life Scienceshttp://incospharm.com/

Last Round

VC Round

Oct 1, 2021

Company Overview

Incospharm Corporation is a biotechnology company that develops bioactive materials and peptide-based ingredients for the cosmetic and pharmaceutical industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Fashion & Beauty, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

bioactive ingredientscosmetic ingredientspeptide designautophagy-modulating peptidesskincare R&Dcosmeceuticalsnanoparticlesanti-aging ingredientsexosome-like nanoparticlesdermatological ingredientsdrug discoverybio-processed ingredientscheminformaticsclean beauty

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Incospharm Corporation Comparables

Compare Incospharm Corporation with similar companies based on industry and business-model similarity.

Incospharm Corporation comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
LipoTrue
88%
CODIF Technologie Naturelle
80%
Naolys
79%

Incospharm Corporation Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundOct 1, 2021
VC RoundDec 3, 2018

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 1, 2021

    $844K raised in a VC Round.

  • Dec 3, 2018

    Raised a VC Round with Skin Reverse Lab participating.

Incospharm Corporation Filings

Explore SEC and related filing metadata, where available.

Incospharm Corporation filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Incospharm Corporation's valuation, stock price, and market status.

Is Incospharm Corporation a public or private company?

Incospharm Corporation is a private company.

What is the current stock price of Incospharm Corporation?

Incospharm Corporation is a private company with no public stock price. Caplight tracks Incospharm Corporation's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Incospharm Corporation worth (valuation)?

Valuation information for Incospharm Corporation is not publicly available.

Can I buy Incospharm Corporation stock?

Incospharm Corporation shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Incospharm Corporation's last funding round?

Incospharm Corporation's most recent funding round was VC Round on October 1, 2021.

Who are the main investors in Incospharm Corporation?

Investor information for Incospharm Corporation is not publicly disclosed.

Will Incospharm Corporation IPO soon?

No public IPO plans have been announced for Incospharm Corporation.

How can I track Incospharm Corporation secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Incospharm Corporation's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDaejeon
Year Founded2011
Last FundingOct 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?